9
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Corneal endothelial cell loss after Baerveldt glaucoma drainage device implantation in the anterior chamber

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Purpose

          To investigate central and peripheral corneal endothelial cell density ( ECD) in relation to Baerveldt ( BV) glaucoma drainage device ( GDD) tube corneal ( TC) distance.

          Methods

          Prospective study of all patients scheduled for glaucoma tube surgery with 36 months follow‐up. A BV GDD was inserted into the anterior chamber ( AC). Anterior segment optical coherence tomography (AS‐OCT) scans were made to determine the TC distance. Central and peripheral ECD was measured, preoperatively and at 3, 6, 12, 24 and 36 months postoperatively.

          Results

          Fifty‐three eyes were included [primary open‐angle glaucoma, ( n = 13); secondary glaucoma, ( n = 30); and primary angle‐closure glaucoma, ( n = 10)]. Central ECD significantly decreased during follow‐up, with a mean decrease of 4.54% per year (p < 0.001), and 6.57% in the peripheral quadrant closest to the BV GDD tube ( PQC, p < 0.001). In the PQC, a yearly decrease of 1.57% was shown after transiridial tube placement versus 7.43% after placement ‘free’ into the AC (p = 0.006). Endothelial cell (EC) loss was related to TC distance (mean 1.69 mm), with a central loss of 6.20% and 7.25% in the PQC per year with shorter TC distances, versus a central loss of 4.11% and 5.77% in the PQC per year with longer TC distances (outside mean ± 2 SD, p < 0.001). A difference in EC loss by glaucoma subtype was not identified.

          Conclusion

          The TC distance is of significant influence on corneal ECD, a shorter TC distance causing more severe EC loss, especially in the PQC. Transiridial placement of the BV GDD tube seems safer than placement ‘free’ into the AC.

          Related collections

          Most cited references16

          • Record: found
          • Abstract: found
          • Article: not found

          Central corneal endothelial cell changes over a ten-year period.

          To obtain longitudinal data to estimate long-term morphometric changes in normal human corneal endothelia. Ten years after an initial study, the authors rephotographed the central corneal endothelium of 52 normal subjects with the same contact specular microscope. The findings for the 10 subjects younger than 18 years of age at the initial examination were considered separately. For the remaining 42 adult subjects, the time between examinations averaged 10.6 +/- 0.2 years (range, 10.1 to 11 years). At the recent examination, these subjects' ages averaged 59.5 +/- 16.8 years (range, 30 to 84 years). Outlines of 100 cells for each cornea were digitized. For the 42 adult subjects, the mean endothelial cell density decreased during the 10.6-year interval from 2715 +/- 301 cells/mm2 to 2539 +/- 284 cells/mm2 (P < 0.001). The calculated exponential cell loss rate over this interval was 0.6% +/- 0.5% per year. There was no statistically significant correlation between cell loss rate and age. During the 10.6-year interval, the coefficient of variation of cell area increased from 0.26 +/- 0.05 to 0.29 +/- 0.06 (P < 0.001), and the percentage of hexagonal cells decreased from 67% +/- 8% to 64% +/- 6% (P = 0.003). For the 10 subjects 5 to 15 years of age at the initial examination, the exponential cell loss rate was 1.1% +/- 0.8% per year. Human central endothelial cell density decreases at an average rate of approximately 0.6% per year in normal corneas throughout adult life, with gradual increases in polymegethism and pleomorphism.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Follow-up of the original cohort with the Ahmed glaucoma valve implant.

            To study the long-term results of the Ahmed glaucoma valve implant in patients with complicated glaucoma in whom short-term results have been reported. In this multicenter study, we analyzed the long-term outcome of a cohort of 60 eyes from 60 patients in whom the Ahmed glaucoma valve was implanted. Failure was characterized by at least one of the following: intraocular pressure greater than 21 mm Hg at both of the last two visits less than 6 mm Hg at both of the last two visits, loss of light perception, additional glaucoma surgery, devastating complications, and removal or replacement of the Ahmed glaucoma valve implant. Devastating complications included chronic hypotony, retinal detachment, malignant glaucoma, endophthalmitis, and phthisis bulbi; we also report results that add corneal complications (corneal decompensation or edema, corneal graft failure) as defining a devastating complication. The mean follow-up time for the 60 eyes was 30.5 months (range, 2.1 to 63.5). When corneal complications were included in the definition of failure, 26 eyes (43%) were considered failures. Cumulative probabilities of success at 1, 2, 3, and 4 years were 76%, 68%, 54%, and 45%, respectively. When corneal complications were excluded from the definition of failure, 13 eyes (21.5%) were considered failures. Cumulative probabilities of success at 1, 2, 3, and 4 years were 87%, 82%, 76%, and 76%, respectively. Most of the failures after 12 months of postoperative follow-up were because of corneal complications. The long-term performance of the Ahmed glaucoma valve implant is comparable to other drainage devices. More than 12 months after the implantation of the Ahmed glaucoma valve implant, the most frequent adverse outcome was corneal decompensation or corneal graft failure. These corneal problems may be secondary to the type of eyes that have drainage devices or to the drainage device itself. Further investigation is needed to identify the reasons that corneal problems follow drainage device implantation.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Changes in corneal endothelial cells after Ahmed glaucoma valve implantation: 2-year follow-up.

              To evaluate changes in corneal endothelial cells after Ahmed glaucoma valve (AGV) implantation for the treatment of refractory glaucoma. Observational case series. We prospectively evaluated the change in density and shape of the corneal endothelium in 41 patients (41 eyes) who had undergone AGV implantation for the treatment of refractory glaucoma. Corneal specular microscopy was performed on the superior, supratemporal, supranasal, and central areas with a noncontact specular microscope before surgery and 1, 6, 12, 18, and 24 months after surgery. The changes at each time point were compared with those at baseline and with those of the control group, which consisted of 20 contralateral glaucomatous eyes receiving antiglaucoma medications. The mean follow-up was 19.1 months. The average percentage decrease in corneal endothelial cell count was 5.8% at 1 month, 11.5% at 6 months, 15.3% at 12 months, 16.6% at 18 months, and 18.6% at 24 months after surgery. The changes were statistically significant compared with those at baseline and those of the control eye at all time points during the study period (P < .05). The supratemporal area, the closest site to the tube, showed the greatest decrease in endothelial cell density, by 22.6%, whereas the central cornea showed the smallest decrease, by 15.4%, at 24 months after surgery. There was statistically significant corneal endothelial cell loss in the operated eye after AGV implant surgery. The corneal endothelial cell loss increased with time: 15.3% at 12 months and 18.6% at 24 months after surgery, on average, in all measured areas.
                Bookmark

                Author and article information

                Contributors
                a.n.tan@lumc.nl
                Journal
                Acta Ophthalmol
                Acta Ophthalmol
                10.1111/(ISSN)1755-3768
                AOS
                Acta Ophthalmologica
                John Wiley and Sons Inc. (Hoboken )
                1755-375X
                1755-3768
                06 August 2016
                February 2017
                : 95
                : 1 ( doiID: 10.1111/aos.2017.95.issue-1 )
                : 91-96
                Affiliations
                [ 1 ] Department of OphthalmologyLeiden University Medical Center LeidenThe Netherlands
                [ 2 ] Maastricht University Medical CenterUniversity Eye Clinic Maastricht MaastrichtThe Netherlands
                [ 3 ] Department of OphthalmologyUniversity Medical Center Groningen GroningenThe Netherlands
                Author notes
                [*] [* ] Correspondence:

                Annelie N. Tan, MD

                Department of Ophthalmology

                Leiden University Medical Center

                PO Box 9600

                2300 RC Leiden

                The Netherlands

                Tel: +31715262374

                Fax: +31715266576

                Email: a.n.tan@ 123456lumc.nl

                Article
                AOS13161
                10.1111/aos.13161
                5298043
                27495264
                ea0b2fe6-2416-4ee1-a0c5-41018595e7fe
                © 2016 The Authors. Acta Ophthalmologica published by John Wiley & Sons Ltd on behalf of Acta Ophthalmologica Scandinavica Foundation and European Association for Vision & Eye Research

                This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

                History
                : 13 March 2015
                : 10 May 2016
                Page count
                Figures: 2, Tables: 4, Pages: 6, Words: 4578
                Categories
                Original Article
                Original Articles
                Custom metadata
                2.0
                aos13161
                February 2017
                Converter:WILEY_ML3GV2_TO_NLMPMC version:5.0.5 mode:remove_FC converted:08.02.2017

                Ophthalmology & Optometry
                anterior segment oct,corneal endothelial cell loss,glaucoma,glaucoma drainage implants

                Comments

                Comment on this article